Hot Investor Mandate: Taiwan Based VC Firm Invests Up to $6M in Global Life Science Companies with Taiwan Market Potential

19 Sep

A venture capital firm founded with headquarters in Taipei City, Taiwan, with additional partners based in Silicon Valley, Korea, Singapore, and Japan, formed a fund with local and international investors. The firm has the capacity to invest in companies they identify as a strong fit, with initial investments typically in the $1-6 M range. The firm is looking for companies globally but would prefer companies that have Taiwan angle.

The firm is an opportunistic investor that currently considering Therapeutics, Medical Devices, Diagnostics, Biotechnology R&D, and Healthcare IT companies. The firm is open to many sectors in therapeutics but prefers companies that are into phase I of clinical trials or later. The firm is open to medical devices with all FDA regulatory pathways, including 510k, PMA, and software-enabled device. The firm invest in any phases in medical devices and diagnostics with a preference for those with in human data. The firm looks into any indications except orphan disease.

The firm currently will invest in privately held companies only. The firm has no specific requirements for management team. The firm can participate as either lead or co-investor and generally requests a board seat or board observer rights in its portfolio company.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: